<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two cases of <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) evolving from <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> are presented </plain></SENT>
<SENT sid="1" pm="."><plain>The first case was diagnosed 18 years ago, and treatment with bolus <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>, <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, and <z:chebi fb="5" ids="50113">androgens</z:chebi> resulted in partial hematological response </plain></SENT>
<SENT sid="2" pm="."><plain>Severe <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> recurred, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M0 by French-American-British classification developed </plain></SENT>
<SENT sid="3" pm="."><plain>The second case was diagnosed 7 years ago </plain></SENT>
<SENT sid="4" pm="."><plain>The patient had HLA DRB1*1501, and treatment with granulocyte colony-stimulating factor (G-CSF), <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>, and methenolone resulted in complete hematological response </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> recurred and did not respond to <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and methenolone or to later treatment with antithymocyte globulin, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> M1 developed </plain></SENT>
<SENT sid="6" pm="."><plain>Cytogenetic studies demonstrated 7q- in the first patient and +8 in the second patient </plain></SENT>
<SENT sid="7" pm="."><plain>No mutations of N-ras or p53 were observed in either patient </plain></SENT>
<SENT sid="8" pm="."><plain>These patients were treated with <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>, aclacinomycin, and G-CSF (CAG) chemotherapy, and the number of leukemic cells decreased substantially </plain></SENT>
<SENT sid="9" pm="."><plain>However, <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> after CAG chemotherapy persisted, and the first patient died of <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and the second patient of <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> </plain></SENT>
</text></document>